6e64: Difference between revisions
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
<StructureSection load='6e64' size='340' side='right'caption='[[6e64]], [[Resolution|resolution]] 3.15Å' scene=''> | <StructureSection load='6e64' size='340' side='right'caption='[[6e64]], [[Resolution|resolution]] 3.15Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[6e64]] is a 4 chain structure with sequence from [ | <table><tr><td colspan='2'>[[6e64]] is a 4 chain structure with sequence from [https://en.wikipedia.org/wiki/Rattus_norvegicus Rattus norvegicus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6E64 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6E64 FirstGlance]. <br> | ||
</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 3.15Å</td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6e64 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6e64 OCA], [https://pdbe.org/6e64 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6e64 RCSB], [https://www.ebi.ac.uk/pdbsum/6e64 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6e64 ProSAT]</span></td></tr> | |||
</table> | </table> | ||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
| Line 15: | Line 16: | ||
</div> | </div> | ||
<div class="pdbe-citations 6e64" style="background-color:#fffaf0;"></div> | <div class="pdbe-citations 6e64" style="background-color:#fffaf0;"></div> | ||
==See Also== | |||
*[[Monoclonal Antibodies 3D structures|Monoclonal Antibodies 3D structures]] | |||
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
[[Category: | [[Category: Rattus norvegicus]] | ||
[[Category: | [[Category: Julien JP]] | ||
[[Category: | [[Category: Kundu P]] | ||
[[Category: | [[Category: Semesi A]] | ||
Latest revision as of 12:51, 23 October 2024
Crystal structure of malaria transmission-blocking antibody 85RF45.1Crystal structure of malaria transmission-blocking antibody 85RF45.1
Structural highlights
Publication Abstract from PubMedInterventions that can block the transmission of malaria-causing Plasmodium falciparum (Pf) between the human host and Anopheles vector have the potential to reduce the incidence of malaria. Pfs48/45 is a gametocyte surface protein critical for parasite development and transmission, and its targeting by monoclonal antibody (mAb) 85RF45.1 leads to the potent reduction of parasite transmission. Here, we reveal how the Pfs48/45 6C domain adopts a (SAG1)-related-sequence (SRS) fold. We structurally delineate potent epitope I and show how mAb 85RF45.1 recognizes an electronegative surface with nanomolar affinity. Analysis of Pfs48/45 sequences reveals that polymorphisms are rare for residues involved at the binding interface. Humanization of rat-derived mAb 85RF45.1 conserved the mode of recognition and activity of the parental antibody, while also improving its thermostability. Our work has implications for the development of transmission-blocking interventions, both through improving vaccine designs and the testing of passive delivery of mAbs in humans. Structural delineation of potent transmission-blocking epitope I on malaria antigen Pfs48/45.,Kundu P, Semesi A, Jore MM, Morin MJ, Price VL, Liang A, Li J, Miura K, Sauerwein RW, King CR, Julien JP Nat Commun. 2018 Oct 26;9(1):4458. doi: 10.1038/s41467-018-06742-9. PMID:30367064[1] From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. See AlsoReferences
|
| ||||||||||||||||